Molecular Quality Control Market Restraints
Inaccurate genetic tests are expected to hinder growth of the molecular quality control market. For instance, in August 2017, Invitae Corporation identified a quality control issue with a hereditary cancer test, which provided false, negative results. This hereditary cancer test is carried out on those patient who have a rare genetic variant in the MSH2 gene which is associated with the Lynch syndrome.
Molecular Quality Control Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients